V
Veeva Systems Inc Class A (VEEV)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
$313.17
+15.82 (+5.32%)
Market Cap: $48.14B
Last updated: Oct 16, 2026 at 1:55 PM ET
Earnings
Performance (10Y)
Beat Rate
100%(40/40)Avg Surprise
+11.04%Streak
52 QUpcoming Estimates
Period ending Oct 31, 2026
EPS Consensus$2.34
Range$2.32 - $2.40
26 analysts
EPS RevisionsNo revisions (7d)
25
0
30dEPS Estimate DriftChange to current
90d ago$2.29+2.5%
60d ago$2.29+2.5%
30d ago$2.28+2.6%
7d ago$2.340.0%
Current$2.34
Revenue Consensus
$935MRange$932M - $945M
24 analysts
Period ending Jan 31, 2027
EPS Consensus$2.54
Range$2.47 - $2.68
27 analysts
Revenue Consensus
$992MRange$982M - $1.0B
27 analysts
Key Metrics
Technical Indicators Dashboard
Moving Averages
SMA 10$291.18
SMA 20$282.32
SMA 50$266.97
SMA 200$204.44
EMA 10$294.16
EMA 20$285.40
EMA 50$264.07
EMA 200$226.51
MACD
Line: 11.10Signal: 9.22Hist: 1.88
ADX
ADX: 41.1+DI: 40.6-DI: 13.8
Aroon & PSAR
Aroon Up100.0
Aroon Down28.0
PSAR$274.63
Bollinger Bands
Upper Band$309.94
Lower Band$254.69
%B Position1957%(Upper)
Band Width1.06
RSI (14-Day)
Overbought
74.0
Momentum Oscillators
Stoch %K81.1
Stoch %D82.4
Williams %R-4.3
ROC (10d)11.1%
Momentum31.24
CCI (20d)177.3
MFI (14d)72.2
Volatility Measures
ATR (14d)$9.86(3.1%)
StdDev (20d)13.81
Hist Vol34.4%(Moderate)
Volume Flow
VWAP$308.24
OBV-14.8M
AD Line-34.8M
CMF (20d)0.035
Volume Metrics
Avg Vol (20d)1.7M
Vol Ratio1.7x(High)
VWMA (20d)$281.08
Pivot Points
R3$309.19
R2$305.34
R1$301.35
Pivot Point$297.50
S1$293.51
S2$289.66
S3$285.67
Advanced Oscillators
TSI34.18
Ultimate Osc62.3
KST100.82
Financial Data
Related GNG Research
Veeva (VEEV): A Record-Keeper Whose Own Books Are Under Audit
Veeva is the regulated life-sciences system of record, owning narrow workflows with high switching costs, layering AI agents across core apps, and focusing on industry penetration not broad enterprise competition Fiscal Q1 revenue $882.9M up 16% YoY, subscription revenue $730.2M up 15%...
Glenn Ford
•Jun 17, 20266/17/26
•190
Life Sciences Software, Quality Compounder
Also mentions:
CRMADBE
News
VEEV Valuation and Fair Value
- P/E
- 39.0x
- Forward P/E
- 30.2x
- EV/EBITDA
- 36.0x
- P/FCF
- 31.0x
- PEG
- 1.2x
- P/B
- 6.8x
VEEV Profitability: Margins, ROIC and FCF
- Gross margin
- 75.0%
- Operating margin
- 29.6%
- Net margin
- 29.3%
- ROE
- 14.4%
- FCF margin
- 47.4%
- FCF yield
- 3.2%
VEEV Competitors
Sector: Healthcare
VEEV Analyst Ratings
- Consensus
- Buy
- Analysts
- 30
- Strong Buy
- 8
- Buy
- 13
- Hold
- 8
- Sell
- 1
- Strong Sell
- 0
VEEV Bull Case vs Bear Case
Bull case
- VEEV converts 47.4% of revenue into free cash flow.
- VEEV has a 29.3% net profit margin.
- VEEV beat EPS estimates in 100.0% of its last 8 reported quarters.
VEEV Earnings: Beat Rate and Next Report
- Beat rate
- 8 of 8 quarters (100.0%)
- Average surprise
- 7.3%
- EPS estimate (fiscal period ending Oct 31, 2026)
- $2.34
- Estimate revisions (30 days, fiscal period ending Oct 31, 2026)
- 25 up, 0 down
Frequently Asked Questions About VEEV
Does VEEV pay dividends?
Veeva Systems Inc Class A (VEEV) does not currently pay a regular dividend.
What is VEEV's P/E ratio?
Veeva Systems Inc Class A has a price-to-earnings (P/E) ratio of 39.05.
What is VEEV's market cap?
Veeva Systems Inc Class A (VEEV) has a market capitalization of $48.14B with a current stock price of $313.17.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.